Clinical Research Directory
Browse clinical research sites, groups, and studies.
Tibulizumab Skin Healing and Inflammation Evaluation for Lasting Defense
Sponsor: Zura Bio Inc
Summary
The study is a Phase 2, multi-center, randomized, double-blind, placebo-controlled study to evaluate the effects of tibulizumab over 16 weeks (Period 1) in adults with hidradenitis suppurativa, followed by a 16-week open-label extension period in which all participants will receive tibulizumab (Period 2)
Official title: A Phase 2, Multi-Center Study Consisting of a Randomized, Placebo-Controlled Period, Followed by an Open-Label Extension Period to Assess the Efficacy, Safety, and Tolerability of Tibulizumab in Adults With Hidradenitis Suppurativa
Key Details
Gender
All
Age Range
18 Years - 70 Years
Study Type
INTERVENTIONAL
Enrollment
225
Start Date
2025-05-16
Completion Date
2027-04
Last Updated
2026-02-12
Healthy Volunteers
No
Conditions
Interventions
Tibulizumab Dose A
Anti BAFF/IL-17 antibody. ZB-106
Tibulizumab Dose B
Anti BAFF/IL-17 antibody. ZB-106
Placebo
ZB-106 Placebo
Locations (56)
Medical Dermatology Specialists (Phoenix)
Phoenix, Arizona, United States
First OC Dermatology Research, Inc.
Irvine, California, United States
Wallace Medical Group, Inc.
Los Angeles, California, United States
Northridge Clinical Trials
Northridge, California, United States
NorCal Clinical Research
Rocklin, California, United States
Florida Academic Dermatology Center
Coral Gables, Florida, United States
Georgia Skin & Cancer Clinic
Savannah, Georgia, United States
Indiana University School of Medicine
Indianapolis, Indiana, United States
The Indiana Clinical Trials Center
Plainfield, Indiana, United States
Equity Medical LLC (Kentucky)
Bowling Green, Kentucky, United States
DS Research of Kentucky, LLC
Louisville, Kentucky, United States
DelRicht LLC
Baton Rouge, Louisiana, United States
Clinical Trials Management, LLC
Metairie, Louisiana, United States
Beth Israel Deaconess Medical Center
Boston, Massachusetts, United States
MediSearch Clinical Trials
Saint Joseph, Missouri, United States
Skin Cancer and Dermatology Institute
Reno, Nevada, United States
Equity Medical
New York, New York, United States
OptiSkin Medical
New York, New York, United States
Optima Research
Boardman, Ohio, United States
ClinOhio Research Services
Columbus, Ohio, United States
Apex Clinical Research Center
Mayfield Heights, Ohio, United States
Best Skin Research LLC
Camp Hill, Pennsylvania, United States
Palmetto Clinical Trial Services
Anderson, South Carolina, United States
DelRicht Research
Mt. Pleasant, South Carolina, United States
International Clinical Research - Tennessee LLC
Murfreesboro, Tennessee, United States
BRCR Global Texas
Katy, Texas, United States
DelRicht Research
Prosper, Texas, United States
Progressive Clinical Research
San Antonio, Texas, United States
Frontier Dermatology
Mill Creek, Washington, United States
University of Washington Medical Center
Seattle, Washington, United States
Dermatology Specialists of Spokane
Spokane, Washington, United States
Ryan Clinical Research Inc.
Newmarket, Ontario, Canada
North York Research Inc
North York, Ontario, Canada
York Dermatology Clinic & Research Centre
Richmond Hill, Ontario, Canada
Centre de recherche Saint-Louis
Québec, Quebec, Canada
Saskatoon Dermatology Centre
Saskatoon, Saskatchewan, Canada
Fachklinik Bad Bentheim
Bad Bentheim, Germany
Klinikum Darmstadt
Darmstadt, Germany
University Hospital Dresden
Dresden, Germany
Versorgungsforschung in der Dermatologie und bei Pflegeberufen (IVDP)
Hamburg, Germany
University Clinic Dermatology Heidelberg
Heidelberg, Germany
Klinik und Poliklinik für Dermatologie und Allergologie
München, Germany
University Hospital Muenster - Münster
Münster, Germany
Semmelweis University
Budapest, Hungary
University of Debrecen
Debrecen, Hungary
RENEW Clinic
Bialystok, Poland
Provita Centrum Medyczne Sp. z o.o. Katowice
Katowice, Poland
Provita Sp. z o. o.
Katowice, Poland
Centrum Badawcze Panaceum Agnieszka Brzezicka, Magdalena Lenkiewicz Sp z .o.o
Malbork, Poland
SOLUMED
Poznan, Poland
Laser Clinic S.C.
Szczecin, Poland
Manufaktura Zdrowia i Urody
Warsaw, Poland
Edificio IMIBIC, Reina Sofia University Hospital
Córdoba, Spain
Gregorio Marañón General University Hospital
Madrid, Spain
Hospital Universitario La Paz
Madrid, Spain
Hospital Universitario Miguel Servet
Zaragoza, Spain